Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. KNC Laboratories Co's current ratio for the quarter that ended in Mar. 2026 was 2.87.
KNC Laboratories Co has a current ratio of 2.87. It generally indicates good short-term financial strength.
The historical rank and industry rank for KNC Laboratories Co's Current Ratio or its related term are showing as below:
FRA:7LW'
s Current Ratio Range Over the Past 10 Years
Min: 1.39 Med: 2.8 Max: 3.99
Current: 2.87
During the past 11 years, KNC Laboratories Co's highest Current Ratio was 3.99. The lowest was 1.39. And the median was 2.80.
FRA:7LW's Current Ratio is ranked better than 70.67% of 1606
companies
in the Chemicals industry
Industry Median: 1.89
vs FRA:7LW: 2.87
KNC Laboratories Co (FRA:7LW) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
KNC Laboratories Co Current Ratio Related Terms
KNC Laboratories Co Current Ratio Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (FRA:7LW) has a Current Ratio of 2.87 as of Mar. 2026. This is near median its historical median of 2.80. Over the past decade, KNC Laboratories Co's Current Ratio has ranged from 1.39 to 3.99. According to the industry distribution chart, KNC Laboratories Co ranks #471 out of 1606 companies in the Chemicals industry, placing it in the top 29.3%.
Is KNC Laboratories Co's Current Ratio too high?
KNC Laboratories Co's current Current Ratio of 2.87 is near median its 10-year median of 2.80. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 3.99. The Chemicals industry median Current Ratio is 1.89. KNC Laboratories Co's value of 2.87 is 51.9% above this industry median. Based on the distribution chart, KNC Laboratories Co ranks #471 out of 1606 companies in the Chemicals industry, which is above the industry midpoint. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's Current Ratio compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #471 out of 1606 companies for Current Ratio. This puts KNC Laboratories Co in the upper half of its industry. The industry median Current Ratio is 1.89. KNC Laboratories Co's value of 2.87 is 51.9% above this benchmark. Historically, KNC Laboratories Co's own Current Ratio has ranged from 1.39 to 3.99 over the past decade. While the company's 10-year median is 2.80 vs. the industry median of 1.89, KNC Laboratories Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,606 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current Current Ratio of 2.87 is 51.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current Current Ratio is 2.87, which is near median its own 10-year median of 2.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current Current Ratio of 2.87. The stock's GF Value™ is €6.31, compared to a current price of €6.30 — trading 0.2% below its estimated fair value. The current Current Ratio is 2.87, which is near median its 10-year median of 2.80 and 51.9% above the Chemicals industry median of 1.89. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current Current Ratio is 2.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of €6.30 is trading 0.2% below its estimated GF Value™ of €6.31.
Key valuation signals for FRA:7LW:
Current Ratio: 2.87 (near median its 10-year median of 2.80)
GF Value™: €6.31 vs. price of €6.30 (0.2% below fair value)
Industry Position: 51.9% above the Chemicals median (#471 of 1606)
No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7LW has been successfully added to your 
